Covid-19 can be Detected with a Simple Eye Test: Here's How

Highlights:

New Tear Film Imager (TFI) device is being studied to detect Covid-19 in the eye's tear film
TFI is a non-invasive that can detect when a virus layer is present in the eye and can quantify it
Clinicians can get a detailed assessment of the health of the tear film in just 40 seconds

New device that measures the tear film is being studied to help detect Covid-19 through a simple eye test, reveals an Israeli company. //

The tear film is a thin fluid layer covering the ocular surface, responsible for the eye's surface comfort, mechanical, environmental and immune protection, and epithelial health. It also forms a smooth refractive surface for vision, Jerusalem Post reported.

Eye Testing Reveals Long COVID
An objective eye test can detect long COVID because it is linked to symptoms of pain, light sensitivity, irritation, and a vague pressure sensation in the eyes.

‘Tear Film Imager (TFI) device can soon diagnose and determine Covid-19 in the eye. The device is fast, affordable, non-invasive and can assess the health of the tear film in just 40 seconds.’

The study seeks to determine whether the Tear Film Imager (TFI) device can "effectively diagnose and determine Covid-19 in a fast, affordable, non-invasive assessment of the eye's tear film", the company Advanced Optical Methods (AdOM) announced late on Thursday.

"The world urgently needs new diagnostic tools to help assess and diagnose aggressive viruses in a non-invasive manner and with speed and efficiency," AdOM CTO Raanan Gefen was quoted as saying.

The TFI device is a non-invasive piece of medical equipment designed to simultaneously measure the mucins -- proteins that hydrate the tear ducts -- and the lipid sub-layers of the eye that prevent the eyes from drying out due to evaporation.

Only 1 in 5 Indians Go for Regular Eye Tests: Study
World Sight Day 2019: Most Indians live with poor eyesight. A new study highlights that only 1 in 5 Indians visit an eye doctor for regular eye checkups.

The diagnostic device works at a resolution depth of a few nanometers, and can provide clinicians with a detailed assessment of the health of the tear film sub-layers within just 40 seconds.

The device can also detect when a "virus layer" is present in the eye and can quantify it. As previously observed in a concept study at Wolfson Medical Center, it has been able to correctly identify corona in patients at the same rate as a PCR test, the report said.

Glaucoma Testing at Home, suggests study
This is the first study in the world that suggests glaucoma eye tests can be performed accurately at home by patients themselves.

"Different SARS variants, as well as aggressive flu variants, are threatening the world population. If proven to have a high correlation to the PCR, this could be a game-changer," Gefen said.

Gefen noted that the TFI device could then be used as a point of diagnostic care in many venues such as airports, sporting arenas and businesses that want to have a simple, non-invasive test to determine the status of entering crowds.

AI to Bring Sharper Focus to Eye Testing: Study
Artificial intelligence can now analyze images of the back of the eye accurately to help clinicians detect and track eye diseases like glaucoma and age-related degeneration better.

The new study will expand on the concept study and observe the use of the TFI in comparison to PCR diagnostic testing on a larger scale. The study, expected to take 30 days to complete, will observe 500 patients, the report said.

Source-IANS